Cleared Traditional

K221965 - FemDx FalloView (FDA 510(k) Clearance)

Mar 2023
Decision
255d
Days
Class 2
Risk

K221965 is an FDA 510(k) clearance for the FemDx FalloView. This device is classified as a Falloposcope (Class II - Special Controls, product code MKO).

Submitted by Femdx Medsystems, Inc. (Santa Clara, US). The FDA issued a Cleared decision on March 17, 2023, 255 days after receiving the submission on July 5, 2022.

This device falls under the Obstetrics & Gynecology FDA review panel. Regulated under 21 CFR 884.1690.

Submission Details

510(k) Number K221965 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 05, 2022
Decision Date March 17, 2023
Days to Decision 255 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF

Device Classification

Product Code MKO - Falloposcope
Device Class Class II - Special Controls
CFR Regulation 21 CFR 884.1690